InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: None

Monday, 05/21/2018 11:57:48 AM

Monday, May 21, 2018 11:57:48 AM

Post# of 448
tweet


BioWorld
? @BioWorld
3m3 minutes ago

$NBRV shares down 12% in heavy volume after premarket surge on top-line data from pivotal ph 3 trial of oral lefamulin in CABP, which hit the FDA/EMA primary endpoint of noninferiority vs moxifloxacin but showed higher TEAE rate in lefamulin arm; NDA filing expected in 4Q